OP-136 Relationship Between Serum Anti-M2- muscarinic Receptor Levels and Atrial Electromechanical Delay in Patients Diagnosed with Paroxysmal Atrial Fibrillation

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-136 Relationship Between Serum Anti-M2- muscarinic Receptor Levels and Atrial Electromechanical Delay in Patients Diagnosed with Paroxysmal Atrial Fibrillation

Objectives Animal studies have demonstrated that rabbits immunized against M2- muscarinic receptors (M2- R) had longer intra-atrial activation times and shorter atrial effective refractory periods. Atrial electromechanical delay (AEMD) determined…

read more

OP-134 Renal Function Reflected with Serum Beta-trace Protein Level is an Independent Predictor of Paroxysmal Atrial Fibrillation

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-134 Renal Function Reflected with Serum Beta-trace Protein Level is an Independent Predictor of Paroxysmal Atrial Fibrillation

Objectives Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Epidemiologic studies have reported an increased prevalence of AF with increasing age and comorbidities such as renal…

read more

OP-133 The Relationship between HbA1c and Atrial Fibrillation after Off-pump Coronary Artery Bypass Surgery in Diabetic Patients

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-133 The Relationship between HbA1c and Atrial Fibrillation after Off-pump Coronary Artery Bypass Surgery in Diabetic Patients

Objective Diabetes mellitus is a risk factor for mortality and morbidity after off-pump coronary bypass grafting (OPCAB), and hemoglobin A1c (HbA1c) is the most convenient marker for monitoring glycemic control…

read more

OP-135 Relationship Between Serum Galectin-3 Levels and Atrial Electromechanical Delay in Patients with Paroxysmal Atrial Fibrillation

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-135 Relationship Between Serum Galectin-3 Levels and Atrial Electromechanical Delay in Patients with Paroxysmal Atrial Fibrillation

Objectives Left atrial (LA) interstitial fibrosis is known to have a role in the initiation and maintenance of atrial fibrillation (AF). Although the role of galectin-3 in the pathogenesis of…

read more

OP-132 The Relationship of Postoperative Atrial Fibrillation with the Use of Blood Product and Levels of Postoperative Hemoglobin in Patients Who Underwent Coronary Artery Bypass Surgery

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-132 The Relationship of Postoperative Atrial Fibrillation with the Use of Blood Product and Levels of Postoperative Hemoglobin in Patients Who Underwent Coronary Artery Bypass Surgery

Objective Atrial fibrillation (AF) is the most common arrhythmia after cardiac surgery. The aim of this study is to evaluate the relationship of postoperative atrial fibrillation (POAF) with the use of blood…

read more

OP-130 Development of Arrhythmogenic Cardiac Cardiomyopathy in Patients with Ventricular Extrasystoles

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-130 Development of Arrhythmogenic Cardiac Cardiomyopathy in Patients with Ventricular Extrasystoles

Aim To find scintigraphic criterions of beginning of arrhythmogenic cardiomyopathy in patients with ventricular extrasystoli (VE). Material-Methods 63 patients with ventricular extrasystoles was included in the study. 29 mean, 34…

read more

OP-131 Does Continuous Insulin Therapy Reduce Postoperative Supraventricular Tachycardia Incidence after Coronary Artery Bypass Operations in Diabetic Patients?

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-131 Does Continuous Insulin Therapy Reduce Postoperative Supraventricular Tachycardia Incidence after Coronary Artery Bypass Operations in Diabetic Patients?

Objective To compare continuous insulin infusion (CII) and intermittent subcutaneous insulin therapy for preventing supraventricular tachycardia. The authors propose that continuous insulin therapy is more effective to reduce supraventricular tachycardias….

read more

OP-128 Localization of Conduction Gaps Following Pulmonary Vein Isolation Using the Second Generation Cryoballoon

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-128 Localization of Conduction Gaps Following Pulmonary Vein Isolation Using the Second Generation Cryoballoon

Objective Conduction recovery characterizations after pulmonary vein isolation (PVI) using the first generation cryoballoon (CB) were already described. The aim of this study was to characterize the conduction recovery localization in…

read more

OP-129 Catheter Ablation of Drug Refractory Electrical Storm in Ischemic Cardiomyopathy: Single Centre Experience

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-129 Catheter Ablation of Drug Refractory Electrical Storm in Ischemic Cardiomyopathy: Single Centre Experience

Background Electrical storm (ES) is known as a life-threatening pathology which requires immediate and effective treatment due to increased morbidity and mortality. Catheter ablation provides an effective therapeutic option especially…

read more

OP-127 Clinical Impact of the Bonus Freeze in Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Using the Second Generation Cryoballoon

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-127 Clinical Impact of the Bonus Freeze in Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Using the Second Generation Cryoballoon

Background Bonus application during pulmonary vein isolation using the novel second generation Cryoballoon is commonly performed. In this study, we aimed to investigate the clinical impact of the bonus freeze on…

read more
Get Clinical Tree app for offline access